From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 421,100 shares, representing 0.25% for CNY 5.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.13 CNY | -2.88% | -10.21% | -16.75% |
1st Jan change | Capi. | |
---|---|---|
-16.75% | 284M | |
+17.39% | 8.48B | |
+6.26% | 7.6B | |
+7.55% | 6.39B | |
-7.57% | 3.71B | |
-5.30% | 3.75B | |
-1.78% | 1.36B | |
-27.39% | 1.11B | |
+18.29% | 1.02B | |
-9.48% | 924M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.